Top analysts on stock perps · Analyst
Michael Leuchten (Jefferies): analyst track record on stock perps
Michael Leuchten of Jefferies on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars0.4★
Success50%
Excess return-3.9%
rank#11,573
Ratings268
ratings on stock perps15
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 67 | 67 |
| Stock | 17 | 17 |
| Buy / hold / sell | 47 / 7 / 13 | 47 / 7 / 13 |
| Upgrades / downgrades / initiations | 1 / 0 / 1 | 1 / 0 / 1 |
| Price targets hit / missed | 14 / 53 (21%) | 14 / 53 (21%) |
| Avg. return after a rating (TipRanks) | -7.9% | -7.9% |
| Best / worst call | +97.8% / -32.4% | +97.8% / -32.4% |
After buy calls: not enough measured cases yet
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $AZN AstraZeneca PLC | Buy · Reiterated | $242 | +40.9% | May 13, 2026 |
Recent ratings
- May 13, 2026 $AZN: Reiterated · Buy · $242 · article
- Apr 30, 2026 $AZN: Maintained · Buy · $241 · article
- Apr 10, 2026 $AZN: Maintained · Buy · $241 · article
- Mar 31, 2026 $AZN: Maintained · Buy · $241 · article
- Mar 27, 2026 $AZN: Maintained · Buy · $241 · article
- Mar 6, 2026 $AZN: Maintained · Buy · $241 · article
- Feb 10, 2026 $AZN: Maintained · Buy · $201 · article
- Dec 1, 2025 $AZN: Maintained · Buy · $201 · article
- Nov 10, 2025 $AZN: Reiterated · Buy · $201 · article
- Oct 26, 2025 $AZN: Upgraded · Buy · $201 · article
- Sep 11, 2023 $AZN: Maintained · Buy · $174 · article
- Jul 12, 2023 $AZN: Upgraded · Buy · $174 · article
- Jul 4, 2023 $AZN: Maintained · Hold · $167 · article
- Jun 19, 2023 $AZN: Maintained · Hold · $167 · article
- Jun 5, 2023 $AZN: Maintained · Hold · $167 · article
Michael Leuchten0.4★ · 50% success · -3.9% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.